ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 58 filers reported holding ANNOVIS BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 117,256 | $3,101,000 | 0.65% |
| Lokken Investment Group LLC | 17,411 | $486,000 | 0.43% |
| Worth Venture Partners, LLC | 29,968 | $836,000 | 0.40% |
| Diametric Capital, LP | 16,837 | $470,000 | 0.36% |
| Sterling Investment Advisors, Ltd. | 31,678 | $884,000 | 0.28% |
| EAM Investors, LLC | 44,640 | $1,245,000 | 0.19% |
| Ikarian Capital, LLC | 193,368 | $5,395,000 | 0.18% |
| Modera Wealth Management, LLC | 40,646 | $1,134,000 | 0.07% |
| RKL Wealth Management LLC | 10,000 | $279,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 21,967 | $613,000 | 0.02% |